OnKure Therapeutics, Inc.: Form 8-K, filed Dec 14, 2023
Filed with the SEC on Dec 14, 2023 and accepted by EDGAR at Dec 14, 2023, 09:26 ET.
Items reported
- Item 2.05 Exit or disposal costs
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-23-295039. Last ingested by Listed: Nov 4, 2026, 17:06 ET. Listed shows no prices and gives no investment advice.